Microsoft Word - LOPA Echo Press Release Final


5777 W. Century Blvd. Suite 360

Los Angeles, CA 90045

310-258-5000

LOPA Brings Echocardiography In-House And Saves More Lives

LOS ANGELES, CA (May 12, 2015) - The Louisiana Organ Procurement Organization (LOPA) is saving more lives by recovering more hearts and organs after having several of its transplant coordinators trained in administering echocardiogram exams. LOPA had coordinators trained in echocardiography through a unique course delivered by CompuMed, Inc. and West Coast Ultrasound Institute (WCUI). The Basic Echocardiography for the Transplant Coordinator course is one of the only ultrasound courses in the country that is customized to the specific needs of the

Organ Procurement Organization (OPO)

community. By training its transplant coordinators in echocardiography,

LOPA is increasing its organ yield through its ability to administer serial echocardiogram exams twenty-four hours a day and seven days a week on demand.

"Recently, we recovered a heart which would have been impossible to recover using our old model. After attending the CompuMed/WCUI course, one of our coordinators, Bo Credeur, was able to perform an echo that resulted in a

transplanted heart. Without having this

skillset in-house, we would not even have pursued this case because the

chances of recovery were very slim due to the case profile and because the hospital sonographer was unavailable. Our early success has already justified the investment we have made in the course and equipment and we are now in the process of expanding this initiative," said Joey Boudreaux, LOPA's Chief Clinical Officer.

"Joey Boudreaux and the LOPA team are trailblazers in revolutionizing the OPO industry to save more lives. We're humbled that CompuMed's Enterprise OPO Solution is playing a role in their success," said W. Scott Rombach, CompuMed's President and CEO.

Please contact CompuMed for specifics regarding the Basic Echocardiography for the Transplant Coordinator course. Information on CompuMed's Enterprise OPO Solution is provided at compumedinc.com.

Further information on West Coast Ultrasound Institute is available at wcui.edu.

About CompuMed, Inc.

CompuMed, Inc. (OTCPink: CMPD) Enterprise Telemedicine Solutions provide patients with the highest level of clinical care at reduced costs. Its telecardiology and teleradiology offerings provide real-time access to U.S. Board-Certified specialists through cloud-based technology and integrated medical devices to medical facilities anywhere in the world. The company has been in business over 26 years and services over 1,000
clinical settings. CompuMed is headquartered in Los Angeles, CA. Visit CompuMed at www.compumedinc.com.

Forward-Looking Statements

Statements contained in this report, such as statements about revenue, operations, and earnings growth and other financial results are forward-
looking statements pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All such forward-looking statements including statements concerning the Company's plans, objectives, expectations and intentions are based largely on management's expectations and are subject to and qualified by risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. These statements are subject to uncertainties and risks including, without limitation, product and service demand and acceptance, changes in technology, ability to raise capital, the availability of appropriate acquisition candidates and/or business partnerships, economic conditions, the impact of competition and pricing, capacity and supply constraints or difficulties, government regulation and other risks identified in the Company's filings with the Securities and Exchange Commission and OTC Pink operated by OTCMarkets. All such forward- looking statements are expressly qualified by these cautionary statements. The Company expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect events, conditions or circumstances on which any such statement is based after the date hereof, except as required by law.
CompuMed, Inc. Investor Relations: investorrelations@compumed.net or (310) 258-5000 x117

distributed by